KI-CDK9d-32
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-173523-1MG | 1 mg | 602,00 | Add | |
| HY-173523-5MG | 5 mg | 1'440,00 | Add | |
| HY-173523-1ML | 10mM/1mL | 2'219,00 | Add | |
| HY-173523-10MG | 10 mg | 2'345,00 | Add | |
| HY-173523-25MG | 25 mg | 4'320,00 | Add | |
| HY-173523-50MG | 50 mg | 6'477,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
KI-CDK9d-32 is a CDK9 PROTAC degrader (DC50: 0.89 nM). KI-CDK9d-32 promotes the ubiquitination and degradation of CDK9. KI-CDK9d-32 inhibits the MYC pathway and disrupts nucleolar homeostasis. KI-CDK9d-32 has anticancer activity. (Pink: CDK9 ligand (HY-153718); Blue: E3 ligase CRBN ligand (HY-163233); Black: Linker (HY-W011657); E3 ligase CRBN ligand-linker conjugate (HY-173525))[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 98.99% |
| Molecular Formula | C39H45N9O4 |
| Molecular Weight | 703.83 |
| CAS-Number | 3054009-82-1 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |